Cibc World Markets Corp Biotechnology

Cibc World Markets Corp

$16.6 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
MDXG Mimedx Group, Inc.	$857M	$106,000 0.0% of portfolio	11,096	Q4 2024 New
ADPT Adaptive Biotechnologies Corp	$1.1B	$65,000 0.0% of portfolio	10,839	Q4 2024 New
MRVI Maravai Lifesciences Holdings, Inc.	$310M	$56,000 0.0% of portfolio	10,336	Q4 2024 New
ENOB Enochian Biosciences Inc	$244M	$49,000 0.0% of portfolio	10,822	Q4 2024 New
RLAY Relay Therapeutics, Inc.	$315M	$46,000 0.0% of portfolio	11,388	Q4 2024 New
NUVB Nuvation Bio Inc.	$395M	$45,000 0.0% of portfolio	16,967	Q4 2024 New
ABUS Arbutus Biopharma Corp	$525M	$44,000 0.0% of portfolio	13,672	Q4 2024 New
XERS Xeris Biopharma Holdings, Inc.	$759M	$44,000 0.0% of portfolio	13,123	Q4 2024 New
ERAS Erasca, Inc.	$186M	$43,000 0.0% of portfolio	17,200	Q4 2024 New
AKBA Akebia Therapeutics, Inc.	$351M	$36,000 0.0% of portfolio	19,468	Q4 2024 New
IBRX Immunity Bio, Inc.	$1.26B	$34,000 0.0% of portfolio	13,546	Q4 2024 New
SVRA Savara Inc	$325M	$33,000 0.0% of portfolio	10,798	Q4 2024 New
TSHA Taysha Gene Therapies, Inc.	$88M	$28,000 0.0% of portfolio	16,405	Q4 2024 New
ALLO Allogene Therapeutics, Inc.	$223M	$25,000 0.0% of portfolio	12,013	Q4 2024 New
OCGN Ocugen, Inc.	$173M	$21,000 0.0% of portfolio	26,787	Q4 2024 New
SANA Sana Biotechnology, Inc.	$325M	$20,000 0.0% of portfolio	12,372	Q4 2024 New
PROK Prokidney Corp Ord Shs Cl A(Cy	$56M	$17,000 0.0% of portfolio	10,261	Q4 2024 New
HRTX Heron Therapeutics, Inc.	$268M	$16,000 0.0% of portfolio	10,986	Q4 2024 New
MRSN Mersana Therapeutics, Inc.	$36.9M	$15,000 0.0% of portfolio	10,616	Q4 2024 New
NKTR Nektar Therapeutics	$139M	$15,000 0.0% of portfolio	16,707	Q4 2024 New
CHRS Coherus Bio Sciences, Inc.	$65.3M	$14,000 0.0% of portfolio	10,412	Q4 2024 New
PGEN Precigen, Inc.	$331M	$14,000 0.0% of portfolio	12,610	Q4 2024 New
XFOR X4 Pharmaceuticals, Inc	$17.2M	$12,000 0.0% of portfolio	15,726	Q4 2024 New
ATOS Atossa Therapeutics, Inc.	$86.1M	$11,000 0.0% of portfolio	11,837	Q4 2024 New
LYEL Lyell Immunopharma, Inc.	$134M	$9,000 0.0% of portfolio	15,039	Q4 2024 New
VERU Veru Inc.	$40.9M	$8,000 0.0% of portfolio	12,362	Q4 2024 New
LXRX Lexicon Pharmaceuticals, Inc.	$108M	$7,000 0.0% of portfolio	10,744	Q4 2024 New
LCTX Lineage Cell Therapeutics, Inc.	$83.2M	$6,000 0.0% of portfolio	13,825	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.